Your browser doesn't support javascript.
loading
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas.
Gounder, Mrinal M; Bauer, Todd M; Schwartz, Gary K; Weise, Amy M; LoRusso, Patricia; Kumar, Prasanna; Tao, Ben; Hong, Ying; Patel, Parul; Lu, Yasong; Lesegretain, Arnaud; Tirunagaru, Vijaya G; Xu, Feng; Doebele, Robert C; Hong, David S.
Afiliação
  • Gounder MM; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, NY.
  • Bauer TM; Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, TN.
  • Schwartz GK; Columbia University Vagelos School of Medicine, New York, NY.
  • Weise AM; Barbara Ann Karmanos Cancer Institute, Karmanos Cancer Institute, Detroit, MI.
  • LoRusso P; Smillow Cancer Hospital at Yale-New Haven, New Haven, CT.
  • Kumar P; Daiichi Sankyo Inc, Basking Ridge, NJ.
  • Tao B; Daiichi Sankyo Inc, Basking Ridge, NJ.
  • Hong Y; Daiichi Sankyo Inc, Basking Ridge, NJ.
  • Patel P; Daiichi Sankyo Inc, Basking Ridge, NJ.
  • Lu Y; Daiichi Sankyo Inc, Basking Ridge, NJ.
  • Lesegretain A; Daiichi Sankyo Inc, Basking Ridge, NJ.
  • Tirunagaru VG; Rain Oncology Inc, Newark, CA.
  • Xu F; Rain Oncology Inc, Newark, CA.
  • Doebele RC; Rain Oncology Inc, Newark, CA.
  • Hong DS; University of Texas M.D. Anderson Cancer Center, Houston, TX.
J Clin Oncol ; 41(9): 1714-1724, 2023 03 20.
Article em En | MEDLINE | ID: mdl-36669146
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipossarcoma / Linfoma / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipossarcoma / Linfoma / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article